Latest Breaking News On - Humanigen inc - Page 6 : comparemela.com

Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia

Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesUnited kingdomShort hillsUniversity of adelaideSouth australiaNew zealandCameron durrantCharlotte wrayDaniel thomasResearch future fundAmerican association of cancer researchDrug administrationHumanigen inc nasdaqHumanigen incHumanigen australia pty ltd

Superior Drilling Products (NYSE:SDPI) Earns Buy Rating from Analysts at StockNews com

Credit Suisse Group restated their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a report issued on Monday morning, Benzinga reports. The firm currently has a $0.50 price objective on the stock. Separately, Cantor Fitzgerald initiated coverage on Humanigen in a research report on Wednesday, January 11th. They set a neutral rating […]

Credit suisse groupYork mellon corpCantor fitzgeraldHumanigen incVirtu financialRenaissance technologiesSuisse groupGet ratingNew york mellon corpHumanigen dailyNasdaq hgenReiterated ratingCredit suisse group ag

Humanigen (NASDAQ:HGEN) Earns Underperform Rating from Credit Suisse Group

Credit Suisse Group reissued their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a research note released on Monday, Benzinga reports. They currently have a $0.50 target price on the stock. Separately, Cantor Fitzgerald initiated coverage on shares of Humanigen in a research note on Wednesday, January 11th. They set a neutral […]

Jpmorgan chase coVirtu financialSwiss national bankBlackrock incTopco ltdHumanigen incCantor fitzgeraldCredit suisse groupSuisse groupGet ratingNational bankHumanigen dailyNasdaq hgenReiterated ratingCredit suisse group ag

Humanigen, Inc (NASDAQ:HGEN) Short Interest Update

Humanigen, Inc. (NASDAQ:HGEN – Get Rating) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 6,540,000 shares, a decline of 9.7% from the February 28th total of 7,240,000 shares. Based on an average trading volume of 3,470,000 shares, the short-interest ratio is presently […]

Humanigen company profileJpmorgan chase coHumanigen incCredit suisse groupVirtu financialTopco ltdCantor fitzgeraldGet ratingSuisse groupHumanigen dailyNasdaq hgen

North American Morning Briefing : Traders Await -3- - Stock market news

U.S.-Russia Rift Complicates Case of Arrested Journal Reporter WASHINGTON-Moscow's arrest of a Wall Street Journal reporter on espionage charges this week broadens a rift between the U.S. and Russia that is already so wide, the two nuclear powers b. | 06:20am

Papua new guineaNorthwest territoriesLa granjaUnited statesUnited kingdomNew yorkEvan gershkovichBarrick niuginiCanaccord genuityGreenwich lifesciences incCapital corpAdvent technologies holdings incDigital ally incFirst quantum mineralsJuniper networks raised to outperform fromSmart share global ltd